More on STRO
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $10.29 |
|
|||
| Open | $10.22 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $10.29 | ||||
| Day Low | $9.16 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 430,837 | ||||
- Sutro Biopharma doses first patient in Phase 1 trial of STRO-006 ADC
- Sutro Biopharma Announces First Patient Dosed in Phase 1 Trial of STRO-006, a Next-Generation ITGB6-Targeting ADC, in Advanced Solid Tumors
- H.C. Wainwright Reiterates Buy Rating on Sutro Biopharma (STRO)
- Sutro Biopharma Announces Participation at the 17th Annual World ADC Conference
- Wells Fargo Assumes Sutro Biopharma (STRO) at Overweight
- Sutro Biopharma names new SVP of business development
- Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development
- Form 4 SUTRO BIOPHARMA, INC. For: Sep 18 Filed by: Gerber Hans-Peter
- Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
- Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: PERCEPTIVE ADVISORS LLC
Entities mentioned with STRO
- Twitter | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Cowen & Co | View Related Stories »
- Show More...
